Skip to main content

convalescent plasma Archives

Convalescent plasma doesn’t help severely ill COVID patients: study

Jul. 7, 2022—A Vanderbilt clinical trial shows that convalescent plasma, widely given to severely ill patients hospitalized with COVID-19 during the pandemic, does not improve their ability to survive or recover

Read more


Convalescent plasma improved survival in COVID-19 patients with blood cancers

Feb. 5, 2021—Treatment with convalescent plasma vastly improved the survival rate of patients hospitalized for COVID-19 who also had hematologic malignances that compromise the immune system, according to new data released by the COVID-19 and Cancer Consortium (CCC19).

Read more


HHS Secretary Azar visits VUMC

Sep. 17, 2020—U.S. Health and Human Services Secretary Alex Azar visited VUMC Tuesday, Sept. 15, to learn more about the Medical Center’s ongoing Moderna COVID-19 vaccine trial and the convalescent plasma trial.

Read more


VUMC awarded $34 million to lead nationwide convalescent plasma study

Aug. 21, 2020—Vanderbilt University Medical Center has been awarded a one-year, $34-million grant by the National Center for Advancing Translational Sciences, part of the National Institutes of Health, to conduct a nationwide study of “convalescent plasma” as a treatment for COVID-19.

Read more


Recent Stories from VUMC News and Communications Publications

Vanderbilt Medicine
Hope
Momentum
VUMC Voice

more